Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate

BACKGROUND: Bispecific antibodies redirecting T cells to the tumor obtain increasing interest as potential cancer immunotherapy. ERY974, a full-length bispecific antibody targeting CD3ε on T cells and glypican 3 (GPC3) on tumors, has been in clinical development However, information on the influence...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Immunother Cancer
Главные авторы: Waaijer, Stijn JH, Giesen, Danique, Ishiguro, Takahiro, Sano, Yuji, Sugaya, Naofumi, Schröder, Carolina P, de Vries, Elisabeth GE, Lub-de Hooge, Marjolijn N
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2020
Предметы:
Clinical/Translational Cancer Immunotherapy
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206965/
https://ncbi.nlm.nih.gov/pubmed/32217763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000548
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы